1 Min Read
* Announces exclusive supply agreement with 4C Medical
* Deal will add cardiovascular tissue engineering from Admedus to 4C Medical’s transcatheter mitral regurgitation treatment technology Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.